Reports Outline Continuous Ambulatory Peritoneal Dialysis Research from Faculty of Medicine Universitas Padjadjaran (Continuous Ambulatory Peritoneal Dialysis Cost-Effectiveness in National Health Insurance Era of Indonesia): Dialysis – Continuous Ambulatory Peritoneal Dialysis

2024 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- New study results on continuous ambulatory peritoneal dialysis have been published. According to news originating from the Faculty of Medicine Universitas Padjadjaran by NewsRx correspondents, research stated, “Essential treatments for patients with end-stage renal disease include Renal Replacement Therapy (RRT) consisting of hemodialysis, peritoneal dialysis, and kidney transplantation. In 2014, dialysis coverage in Indonesia was more than 1.5 trillion, making it the second highest expense in the National Health Insurance (BPJS) expenses.”

Our news correspondents obtained a quote from the research from Faculty of Medicine Universitas Padjadjaran: “This study compared the cost-effectiveness between Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis (HD) in patients treated in Dr. Hasan Sadikin General Hospital. Data were collected from the Urology Department from 2014 to 2017. This was a retrospective observational study on 3 groups of patients: patients with effective CAPD each year as the first group; patients who had experienced repair of CAPD and continued to use it as the second group; and patients who discontinued CAPD due to complications and returned to hemodialysis as the third group. Each group expense was calculated with standard cost insurance for one year in the hospital. The expense was then be compared to the expense of hemodialysis for one year. A total of 89 patients in the CAPD program from 2014-2017 were treated at the department. When compared to HD, the first, second, and third group of CAPD patients experienced a cost reduction of IDR 23.227.857/person, IDR 18.127.857/person, and IDR 1.661.972.000, respectively.”

According to the news reporters, the research concluded: “Total savings from the CAPD program in the hospital was IDR 1.661.972.000 from 2014. It is then concluded that CAPD could reduce the burden of government insurance in a cost-effective manner and is considered a treatment of choice in the National Health Insurance Era.”

For more information on this research see: Continuous Ambulatory Peritoneal Dialysis Cost-Effectiveness in National Health Insurance Era of Indonesia. Majalah Kedokteran Bandung, 2023,55(4):260-263. (Majalah Kedokteran Bandung - http://journal.fk.unpad.ac.id/index.php/mkb/). The publisher for Majalah Kedokteran Bandung is Universitas Padjajaran.

A free version of this journal article is available at https://doi.org/10.15395/mkb.v55n4.2372.

Our news editors report that more information may be obtained by contacting Tjahjodjati Tjahjodjati, Department of Urology, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung. Additional authors for this research include Yasser Kuddah, Zola Wijayanti.

(Our reports deliver fact-based news of research and discoveries from around the world.)